Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

US Patent 11229700 · Granted Jan 25, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD33-, CD16- and CD123-specific single chain triplebody2024
Administration of a bispecific construct binding to CD33 and CD3 for use in a me2021
Combination of epigenetic factors and bispecific compounds targeting CD33 and CD2021
Chimeric serine proteases2003
Recombinant blood-coagulation proteases2001
Chimeric serine proteases2001
Chimeric serine proteases2000